Recognizing and Addressing Risks of Shifting Epidemiology of Pneumococcal Disease in Adults 50+

Overview

Discuss the ongoing burden and shifting epidemiology of pneumococcal disease in adults 50+

Review the robust clinical trial program to help address invasive pneumococcal disease and pneumococcal pneumonia

Highlight CDC recommendations for adult pneumococcal disease, including lowering vaccination age from 65 to 50